Research and development of tumor drugs and drug formulations for difficult and complex diseases

The total investment of the project is 10 million US dollars. The start and end of the project are from month to month. The number of project teams is 20 people. The main business area is the core technology of biological agents. The interested country is the United States, and the interested unit is the United States